La société aptamères

Novaptech

Novaptech is the expert company for the identification, the characterization, the optimization and the functionalization of aptamers for the analytical, diagnostic and therapeutic fields.

Novaptech develops aptamer-based tools and devices for applications in the health, agri-food and environment fields.

Novaptech contributes to collaborative projects or service agreements with academic laboratories and R&D departments of companies worldwide.

Novaptech is a spin-off from Dr. Toulmé ’s academic team, (Inserm, University of Bordeaux, France) which has nearly 30 years of experience in aptamer selection.

30

Lauréat i-LAB 2017

En 2017, Novaptech a reçu un prix régional dans le cadre du concours d'innovation i-LAB

Crédit d'impôt recherche labellisé

Novaptech is certified by the French Ministry for education, research and innovation. Our contract services are therefore eligible for the French R&D tax credit.
You can view the certification ici.

Partenariat / Eurogentec

Eurogentec fournit des produits et services aux scientifiques impliqués dans la recherche en sciences de la vie, le diagnostic moléculaire et le développement thérapeutique. Expert en synthèse à petite et grande échelle, Eurogentec produit une large gamme d'oligonucléotides personnalisés depuis les amorces classiques jusqu'aux séquences très complexes. Novaptech et Eurogentec ont signé un partenariat pour la production d'aptamères sélectionnés par Novaptech.

Conseil d'administration

Marine Faussillon-Laville, PhD

Présidente, Co-fondatrice

Marine holds a Ph.D. in Molecular Genetics from the University of Paris XI – Orsay. Previously working as R&D project leader and medical science liaison before focussing on sales and business development, Marine has over 15 years management experience in the biotech and pharmaceutical industry. Currently Novaptech’ CEO, she brings a wealth of experience and strategic insight to the company that she co-founded with Jean-Jacques Toulmé.

Jean-Jacques Toulmé, PhD

Directeur Scientifique, Co-fondateur

Jean-Jacques got a PhD in Physical Sciences from the University Pierre and Marie Curie, Paris. Affiliated to the French Institute for Medical Sciences (Inserm) he worked on synthetic oligonucleotides first in Paris then in Bordeaux where he created in 1990 a research laboratory dedicated to small RNAs and aptamers that he directed until 2014. He chaired for 15 years the European Institute for Chemistry and Biology at the University of Bordeaux. Jean-Jacques holds presently a Director of Research Emeritus position at Inserm and is the CSO of the company that he co-founded with Marine Laville in 2016.

Biomarker analysis

Nos partenaires

Offres
À propos des Aptamères
À propos de Novaptech
Contact

2 avenue Favard
Entrée 5, 1er étage
33170 GRADIGNAN, FRANCE
contact@novaptech-com.preview-domain.com

À propos de Novaptech
Contact

2 avenue Favard
Entrée #5, 1er étage
33170 GRADIGNAN, FRANCE
contact@novaptech-com.preview-domain.com

© NOVAPTECH 2024

fr_FRFR